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Abstract
Background: Proteomic methodologies increasingly have been applied to the kidney to map the renal cortical
proteome and to identify global changes in renal proteins induced by diseases such as diabetes. While progress
has been made in establishing a renal cortical proteome using 1-D or 2-DE and mass spectrometry, the number
of proteins definitively identified by mass spectrometry has remained surprisingly small. Low coverage of the renal
cortical proteome as well as our interest in diabetes-induced changes in proteins found in the renal cortex
prompted us to perform an in-depth proteomic analysis of mouse renal cortical tissue.
Results: We report a large scale analysis of mouse renal cortical proteome using SCX prefractionation strategy
combined with HPLC – tandem mass spectrometry. High-confidence identification of ~2,000 proteins, including
cytoplasmic, nuclear, plasma membrane, extracellular and unknown/unclassified proteins, was obtained by
separating tryptic peptides of renal cortical proteins into 60 fractions by SCX prior to LC-MS/MS. The identified
proteins represented the renal cortical proteome with no discernible bias due to protein physicochemical
properties, subcellular distribution, biological processes, or molecular function. The highest ranked molecular
functions were characteristic of tubular epithelium, and included binding, catalytic activity, transporter activity,
structural molecule activity, and carrier activity. Comparison of this renal cortical proteome with published
human urinary proteomes demonstrated enrichment of renal extracellular, plasma membrane, and lysosomal
proteins in the urine, with a lack of intracellular proteins. Comparison of the most abundant proteins based on
normalized spectral abundance factor (NSAF) in this dataset versus a published glomerular proteome indicated
enrichment of mitochondrial proteins in the former and cytoskeletal proteins in the latter.
Conclusion: A whole tissue extract of the mouse kidney cortex was analyzed by an unbiased proteomic
approach, yielding a dataset of ~2,000 unique proteins identified with strict criteria to ensure a high level of
confidence in protein identification. As a result of extracting all proteins from the renal cortex, we identified an
exceptionally wide range of renal proteins in terms of pI, MW, hydrophobicity, abundance, and subcellular
location. Many of these proteins, such as low-abundance proteins, membrane proteins and proteins with extreme
values in pI or MW are traditionally under-represented in 2-DE-based proteomic analysis.
Published: 23 May 2008
Proteome Science 2008, 6:15 doi:10.1186/1477-5956-6-15
Received: 4 April 2008
Accepted: 23 May 2008
This article is available from: http://www.proteomesci.com/content/6/1/15
© 2008 Zhao et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Proteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
Page 2 of 15
(page number not for citation purposes)
Background
The essential role of kidneys in normal physiology,
including plasma filtration of metabolic waste products,
acid-base balance, regulation of plasma volume, and hor-
mone secretion, is indicated by the large number of
diverse, life threatening renal diseases. Plasma filtration
and much of the tubular reabsorption takes place in the
renal cortex, an important functional component of the
kidney between the renal capsule and renal medulla, con-
sisting of glomeruli, proximal and distal tubules. Of all
renal pathologies, diabetic nephropathy (DN) has
become the most common cause of renal insufficiency
culminating in end-stage renal failure in the western
world [1]. Although DN has been considered a predomi-
nantly glomerular disorder, recent studies have demon-
strated the importance of tubulointerstitial changes [2-5].
These findings suggest that previous approaches focused
on either glomeruli or tubules are insufficient for a global
understanding of the pathophysiology of complicated
renal diseases such as DN.
Given the importance of the kidney in normal and disease
states, numerous proteomic methodologies increasingly
have been applied to the kidney, and novel combinations
of research tools are now available to identify global
changes in renal protein expression patterns induced by
diseases such as diabetes. This is highly relevant since the
involvement of proteins and the molecular functions they
control is a common denominator in every mechanism
invoked to explain diabetes-induced tissue injury [6-9].
The majority of these investigations has focused on the
identification and quantification of proteins found in
urine [10-15], primarily to identify potential biomarkers
of renal disease [16]. This reflects the non-invasive nature
of the sample collection, its availability, and the observa-
tion that proteins found in urine under pathophysiologi-
cal conditions will reflect altered glomerular and tubular
pathology induced by renal disease [17]. Progress has
been made in establishing a renal cortical proteome using
1-D or 2-DE and mass spectrometry [18], including pro-
teomes of renal cortex [19,20], glomerular cells [21-24],
tubular epithelial cells [25-27], and collecting duct cells
[28]. While thousands of spots can be visualized using 2-
DE, the number of proteins definitively identified by mass
spectrometry has remained surprisingly small [29].
The coverage of renal cortical proteins has been signifi-
cantly improved by fractionating renal cortex tissue into
functional units comprising glomeruli or tubules
[21,30,31]. Using this approach, Miyamoto et al [21]
identified 6,686 unique proteins (one half were identified
with one peptide) representing ~3,000 distinct genes from
purified glomeruli obtained from one human kidney.
Here, we have employed an alternative fractionation strat-
egy to enhance coverage of the renal proteome. We enzy-
matically digested proteins extracted from the entire renal
cortex, then separated the resulting complex peptide mix-
ture into 60 fractions with strong cation exchange media.
Each fraction was further resolved by reversed-phase
media prior to sequencing by LC-MS/MS. We elected to
use this approach since tissue (or subcellular) fractiona-
tion and purification results in the loss of important extra-
cellular and interstitial renal cortical proteins, and our
goal was to identify the entire renal cortical proteome
rather than to describe what might be unique between dif-
ferent functional components or cell types within the
renal cortex. While renal fractionation into functional
units has been shown to improve the proteome coverage,
it does not diminish the complexity of renal protein mix-
tures (glomeruli are composed of multiple cell types,
including blood cells and plasma, endothelial and vascu-
lar smooth muscle cells, mesangial cells, podocytes, infil-
trating leukocytes, etc.). Our renal fractionation strategy
has been widely used previously [32-34], it can be very
complementary to the proteomes generated by fractionat-
ing the renal cortex into major functional components,
and our more integrative approach using the whole renal
cortex can provide important insights into the pathophys-
iology of disease processes affecting the entire renal cortex
In this study, we elected to identify the proteome of the
entire renal cortex tissue by using an unbiased 2D-LC-MS/
MS approach. 2D-LC-MS/MS is a well-documented meth-
odology for analyzing the proteome of complex biologi-
cal systems. Using this approach, Wasburn et al. identified
1,484 proteins from the S. cerevisiae proteome [35], and
Peng et al. [36], using offline two-dimensional chroma-
tography coupled with tandem mass spectrometry, identi-
fied 1,504 yeast proteins from S. cerevisiae from 1 mg of
total protein. Here, we have identified ~2,000 proteins
from the renal cortex. We used a semi-quantitative
approach to determine the relative abundance of the iden-
tified proteins, and report a wide dynamic range of 4
orders of magnitude, with many low-abundance, tubule-
related proteins present in our dataset. We further demon-
strate that the inter-animal variability in identified pro-
teins can be accounted for by the inherent variability in
the mass spectrometry instrumentation.
Methods
Animal and surgical protocols
Male C57BLKS/J mice were purchased from Jackson Labs
(Bar Harbor, Maine) and were housed 2–3/cage in a ster-
ile environment, in a room with a 12 hour light cycle and
free access to standard chow and water in the UTMB Ani-
mal Resource Center in accordance with its IACUC poli-
cies and the Public Health Service Guide for the Care and
Use of Laboratory Animals. At 5 months of age, mice were
anesthetized (ketamine/xylazine; 70/10 mg/kg i.p.), anti-
coagulated (5 units heparin), then exsanguinated prior toProteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
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rapid aortic perfusion with ice-cold PBS to quickly rinse
kidneys free of blood and to deliver protease (10 μg/ml
pepstatin A, 10 μg/ml leupeptin, 10 μg/ml STI, 1 mM
PMSF, 10 μg/ml aprotinin) and phosphatase (1 mM
orthovanadate and 30 mM sodium fluoride) inhibitors,
and DTT (0.5 mM). Both kidneys were removed, decapsu-
lated, flash-frozen in liquid nitrogen, then store at -80°C
until processed for protein extraction.
Tissue processing, protein extraction and tryptic digestion
From each mouse, ~50 mg of kidney cortical tissue were
separated from the medullary portion of each kidney
under magnification with a dissecting microscope and
suspended in 20 fold excess (wt/vol) of TRIzol® reagent
(Invitrogen, Carlsbad, CA). The tissue was homogenized
with 20 stokes of a 1 ml Dounce homogenizer on ice. The
proteins were extracted from the lysate according to the
manufacturer's instructions, and the protein pellet was
dissolved in 250 μl of 8 M guanidinium HCl. The mixture
was diluted with 2250 μl of 100 mM ammonium bicarbo-
nate, and digested with 40 μg of trypsin overnight at
37°C. The tryptic peptide mixture was desalted with a
Sep-Pak® C18 cartridge (Waters, Milford, MA) following
the manufacturer's instructions. Peptides were eluted
from the cartridge with 80% acetonitrile and completely
dried using a speedvac.
Two-dimensional liquid chromatography with tandem 
mass spectrometry (2D LC-MS/MS)
The dried peptide samples were redissolved by adding 20
μl of acetonitrile and diluted with 100 μL of 5 mM ammo-
nium formate, pH 2.7. The peptide mixture was loaded
onto a SCX column (4.6 mm × 25 cm; Poly LC, Columbia,
MD) and separated with a linear gradient from 100%
buffer A (5 mM ammonium formate-20% acetonitrile, pH
2.7) to 25% buffer B (1 M ammonium formate-20% ace-
tonitrile, pH 3.0) over 40 min at a flow rate of 0.8 ml/min
and followed by a linear gradient from 25% buffer B to
60% buffer B over 20 min. The eluate was manually col-
lected after the first salt gradient was started. Sixty frac-
tions corresponding to 0.8 ml each were collected and
dried using a Speedvac. Each SCX fraction was redissolved
in 20 μl of 0.1% TFA and was injected onto a C18 peptide
trap (Agilent, Santa Clara, CA), desalted with 0.2% formic
acid at a flow rate of 10 μl/min for 180 min. Peptides were
eluted from the trap and separated on a reversed phase
nano-HPLC column (PicoFritTM, 75 μm × 10 cm; tip ID
15 μm) with a linear gradient of 0–50% mobile phase B
(0.1% formic acid-90% acetonitrile) in mobile phase A
(0.1% formic acid) over 120 min at 200 nl/min. LC-MS/
MS experiments were performed with a LTQ linear ion
trap mass spectrometer (ThermoFinnigan, San Jose, CA)
equipped with a nanospray source; the mass spectrometer
was coupled on-line to a ProteomX® nano-HPLC system
(ThermoFinnigan, San Jose, CA). The mass spectrometer
was operated in the data-dependent mode using Xcalibur
software. The most intense seven ions in each MS survey
scan were automatically selected for MS/MS.
Data processing
The acquired MS/MS spectra were searched with
SEQUEST algorithm against a composite target-decoy
mouse protein database consisting of the protein
sequences (target) downloaded from SWISSPROT mouse
protein database (downloaded July 2006) and reversed
versions of these sequences (decoy). All SEQUEST
searches were performed on the Bioworks 3.2 platform
(ThermoFinnigan, San Jose, CA) using the followed
parameters: fully tryptic peptide (both tryptic terminus for
all peptides), a mass tolerance of ± 2.0 Da for precursor
ion and ± 1.0 Da for fragment ion. The output data from
these searches were filtered and sorted by the DTASelect
software [37]. Only the top one peptide sequence match
to each acquired MS/MS spectrum was considered. The
criteria used in DTASelect were as follows: First, relatively
conservative criteria (Sp ≥ 300; ΔCn ≥ 0.12; Xcorr of 1.9,
2.0 and 3.0 for data from a singly, doubly or triply charged
precursor ion, respectively) were applied. Second, pro-
teins that passed these thresholds were separated into two
groups: proteins identified with more than one peptide
and proteins identified with one peptide. Third, since the
majority of the false positive identifications in our dataset
were within the group of proteins with one identified pep-
tide, much stricter criteria (Xcorr 2.2, 3.2, or 3.75 for pre-
cursor charge states of 1+, 2+, or 3+, respectively) were
applied to the peptide hits in this group to increase iden-
tification certainty. Forth, if multiple spectra were identi-
fied to match precisely the same sequence and charge
state, only the spectrum with the highest Xcorr was
retained. Finally, proteins that shared all matched pep-
tides with other (homologous) proteins were removed.
The false positive rate (FPR) of identification was esti-
mated as described [38-40]. Briefly, the number of false
positive identification (FP) was estimated by doubling the
passing decoy assignments; the number of true positive
identifications (TP) was estimated by subtracting the FP
from the total passing assignment. The FPR was estimated
by using the followed equation: FPR = FP/(FP+TP).
The normalized spectral abundance factor (NSAF) value
for each protein was calculated as described [41],
in which the total number of tandem MS spectra match-
ing peptides from protein k (SpC) was divided by the pro-
tein length (L), then divided by the sum of SpC/L for all
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Results and Discussion
Reproducibility
First, we examined the reproducibility of protein identifi-
cation between individual mice. Renal cortical tissue was
isolated from three mice, proteins extracted and digested
with trypsin, and each of the three tryptic peptide mix-
tures was separated by SCX into 60 fractions. For each
mouse, 14 consecutive SCX fractions with retention times
between 20 and 34 min were selected for LC-MS/MS anal-
ysis, and the MS data searched against public databases
using the SEQUEST algorithm as described above. We esti-
mated the identification false positive rate (FPR) using a
composite target-decoy database searching strategy
described in the Experimental section. A total of 1,657,
1,484 and 1,592 proteins were identified with ~1% FPR
from each mouse. In each dataset, a normalized spectral
abundance factor (NSAF) value was calculated for each
identified protein. If one protein was identified from
more than one mouse, the NSAF values of the protein
were averaged and a mean, standard deviation (SD) and
coefficient of variation (CV) were calculated. The identi-
fied proteins, including SWISSPROT accession number,
locus ID, protein name, number of amino acids, theoreti-
cal MW and pI, normalized spectral abundance factor
(NSAF; including SD and CV of NSAF if the protein was
identified in 2 or more animals), and the animal from
which each protein was identified are listed [see Addi-
tional file 1]. As shown in Figure 1A, overlap between
datasets was high, with reproducibility of protein identifi-
cation between 72 – 82% for pairwise comparisons and
63 – 71% for all three animals. A total of 2,190 unique
proteins were identified when all three datasets were com-
bined. Normalized spectral abundance factor (NSAF) val-
ues for identified proteins were highly reproducible
between individual mice. For example, a total of 1,038
proteins were identified as common in all three mice, and
the distribution of their NSAF values is shown in Figure
1B. For the majority (97.6%) of these proteins, the CV of
NSAF is less than 1%, indicating that the inter-animal var-
iability in NSAF values is low.
Using protein datasets generated from the 3 mice, we used
NSAF values to estimate the relative abundance of pro-
teins that were identified as common in all three mice ver-
sus unique to an individual mouse. As shown in Figure
1C, NSAF scores were relatively lower when proteins were
identified in only one mouse and relatively higher when
proteins were identified in all three mice. A total of 188
proteins with averaged NSAF scores above 0.001 were
identified in all 3 mice, decreasing to 6 proteins when
identified in 2 out of 3 mice, and 1 protein when identi-
fied in only one mouse.
Conversely, only 1 protein identified in all 3 mice had a
NSAF score lower than 0.00001, while 13 proteins were in
this category when identified in 2 out of 3 mice, and 50
proteins when identified in only one mouse. These results
indicate that high abundance proteins with high NSAF
scores are more likely to be reproducibly identified in
multiple animals.
In order to examine reproducibility of the LC-MS/MS
method, we analyzed one SCX fraction by LC-MS/MS
three times. As shown in Figure 1D, 135 proteins were
common to each MS/MS run. Reproducibility of protein
identification was 72 – 82% for pairwise comparisons and
63 – 69% for triplicate analyses. Since this overlap is in the
same range for individual animals or different mass spec-
trometry runs, these results suggest that the variation in
reproducibility in protein identifications can mostly be
accounted for by the mass spectrometer, and not by vari-
ability between mice. We next compared the NSAF values
of proteins that were identified as common in all three
LC-MS/MS runs versus uniquely identified in individual
LC-MS/MS run. As shown in Figure 1E, we found that rep-
licate analyses of the same sample yielded similar trends
to those from individual mice (Figure 1C). This further
suggests that in our study, the variation in individual mice
is minor and the major causes of the variation in repro-
ducibility in protein identification are the sampling speed
and the dynamic range of the mass spectrometer. Similar
results have been reported by other groups who have
shown that peptide mixtures extracted from one gel band
and analyzed with LC-MS/MS three times results in repro-
ducibility in peptides identified by LC-MS/MS of 60 –
70% [32,42]. More recently, it has been reported that
advanced mass spectrometry methods can unambigu-
ously identify more than 2,000 yeast proteins, the major
limitation derived from a combination of dynamic range
of the sample and effective sequencing speed of the mass
spectrometer [43]. Our results also emphasize the need
for more intelligent acquisition software and mass spec-
trometers with higher dynamic ranges.
Mouse renal cortical proteome
Using a single mouse in which both kidneys were rapidly
perfused with ice-cold PBS and a cocktail of protease and
phosphatase inhibitors to minimize blood contamina-
tion and to preserve renal cortical protein integrity, pep-
tides in all 60 SCX fractions were further separated and
sequenced by nano reversed-phase HPLC with online tan-
dem mass spectrometry as detailed above. Over 600,000
MS/MS spectra were acquired, then used for database
searching with the SEQUEST algorithm. A total of 10,593
unique peptides were identified with ≤1% FPR, and the
complete list of these sequenced peptides used to identify
each protein is found in Additional file 2. The criteria used
for determining the certainties of identification in this
study are more stringent than those used by other investi-
gators [44,45]. These peptides were mapped to 1,966 pro-Proteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
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teins, and the identified proteins, including SWISSPROT
accession number, locus ID, gene name, protein name,
number of unique peptides used in the identification,
sequence coverage (%), number of amino acids, theoreti-
cal MW and pI, subcellular location, protein family,
number of predicted hydrophobic α-helical transmem-
brane domains, and NSAF, are listed alphabetically by
SWISSPROT accession number [see Additional file 3]. Of
1,966 identified proteins, 1,578 (80.3%) proteins were
identified with more than one unique peptide. The
Reproducibility of protein identification between individual mice Figure 1
Reproducibility of protein identification between individual mice. A. Renal cortical proteins isolated from three mice, were 
extracted, digested with trypsin, separated by SCX into 60 fractions, and for each mouse, 14 consecutive SCX fractions with 
retention times between 20 and 34 min were selected for LC-MS/MS analysis. B. The NSAF values of the proteins identified as 
common in all three mice.  , NSAF values of the proteins identified from mouse A;  , NSAF values of the proteins identified 
from mouse B; , NSAF values of the proteins identified from mouse C; and  , the mean of the NSAF values. C. The NSAF val-
ues of the proteins identified from all of the three mice. , the mean of the NSAF values of the proteins identified as common 
in all three mice;  , the mean of the NSAF values of the proteins identified in two out of three mice; , the NSAF values of the 
protein identified in only one mouse. D. To examine reproducibility of the 2D-LC-MS/MS method, we analyzed one SCX frac-
tion by LC-MS/MS three times. E. The NSAF values of the proteins identified from all of the three LC-MS/MS runs. , the 
mean of the NSAF values of the proteins identified as common in all three LC-MS/MS runs; ×, the mean of the NSAF values of 
the proteins identified in two out of three LC-MS/MS runs; and , the NSAF values of the protein identified in only one LC-
MS/MS run.Proteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
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number of proteins that overlapped with the original 3
datasets containing 2,190 proteins was 76% (data not
shown).
We also compared an independent method using 18O-
labeling technology [46] with data-dependent Zoomscan
and MS/MS switching that doubled the duty cycle. Since
we showed there was very little inter-animal variability,
equal amounts of renal cortical extracts from five control
mice were pooled, tryptic peptides labeled using this sta-
ble isotope method, then fractionated into 60 SCX frac-
tions. We found 81% overlap with the 1,966 proteins
identified above (data not shown). These results indicate
that the identification of proteins is highly reproducible at
the level of individual animals, pools from multiple ani-
mals, and different mass spectrometry methods.
Relative abundance of identified proteins
We used NSAF to determine the relative abundance of the
proteins identified in renal cortex. It has been well docu-
mented that abundant proteins are typically identified
with multiple unique peptides from a single 2D-LC-MS/
MS run and that peptides from abundant proteins are
more likely to be re-identified multiple times due to "peak
spreading" within the prior in-line chromatography [47].
Liu and Yates found that spectral counting correlated with
relative protein abundance and could be used to estimate
the abundance of a group of proteins where a large
number of peptides with different properties are available
[48]. This method has been shown to be an effective
quantitative proteomics approach when combined with
MudPIT [41,47,49,50]. Using the 1,966 proteins identi-
fied from the single mouse, DTASelect sorting and filter-
ing yielded 49,965 MS/MS spectra for further analysis. A
calculated NSAF value for each protein is shown in Addi-
tional file 3 and all values are shown graphically in Figure
2. NSAF values of identified proteins fall within the range
from 1.7 × 10-6 to 1.8 × 10-2, indicating that our approach
has a wide dynamic range. More than 100 proteins have
NSAF values greater than 0.002. The 105 most abundant
proteins (5.3% of the total identified proteins) were iden-
tified with 24,259 MS/MS spectra, which account for
48.6% of the total of MS/MS spectra that passed DTASe-
lect filtering. Surprisingly, approximately half of the 105
proteins are mitochondrial proteins and one third are
cytoplasmic proteins, including enzymes, cytoskeleton
proteins, and ribosomal proteins. Of the remaining pro-
teins whose NSAF values are greater than 0.002, most are
nuclear proteins. PDZ domain-containing protein 1
(PDZK1), a plasma membrane protein with an NSAF
value of 0.0052, is highly expressed in renal proximal
tubules and plays a central role in the regulation of polar-
ized tubule cell function and the formation of regulatory
complexes that provide spatial and molecular specificity
to the intracellular signaling [51,52]. In the dataset
reported here, low-abundance proteins such EGF recep-
tor, IGF 2 receptor, MEKK4, MEKK5, and Sp1 have very
low NSAF values (< 1 × 10-5), demonstrating the value of
reduction of sample complexity by our multidimensional
tandem mass spectrometry approach.
Characteristics of identified proteins
We next evaluated proteins based on their pI, MW, hydro-
phobicity, and presence of hydrophobic α-helical trans-
membrane domains. The theoretical pI and MW values of
the 1,966 proteins identified from the single mouse renal
cortex separated into 60 SCX fractions were calculated by
DTASelect software. While ~60% of the identified pro-
teins had theoretical pI values in the pH 5–9 range and
theoretical MW between 20,000 to 100,000 Da, a number
of proteins with extreme values in pI or MW were present
in our dataset (Figure 3). For example, 32 acidic proteins
with a theoretical pI of <4.5 and 122 basic proteins with a
theoretical pI of >10.0 were identified; 29 small proteins
with MW <10,000 Da and 242 proteins with MW >
150,000 Da were identified. These proteins represent a
population of proteins that are rarely identified by 2-DE.
A number of proteins with hydrophobic α-helical trans-
membrane domains were present in our dataset. To locate
the α-helical transmembrane domains, the set of identi-
fied proteins was searched with the SOSUI transmem-
brane prediction algorithm [53-55]. A total of 348
proteins contained at least one predicted hydrophobic α-
helical transmembrane domain (listed in Additonal file
3). Out of the 348 proteins, 120 were identified as plasma
membrane proteins by Ingenuity Pathway Analysis [56] as
NSAF values for every protein [see Additional file 2] are  shown graphically Figure 2
NSAF values for every protein [see Additional file 2] are 
shown graphically. NSAF values of identified proteins fall 
within the range from 1.7 × 10-6 to 1.8 × 10-2.Proteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
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receptors, transporters, ion channels, etc. A number of
integral membrane proteins of subcellular organelles such
as mitochondria, endoplasmic reticulum, and Golgi, were
present in our dataset.
Subcellular location of identified proteins
Using IPA to parse identified proteins into subcellular
compartments, we found more than one half of all iden-
tified proteins were cytoplasmic proteins and Figure 4A
(right side) lists the major cytoplasmic compartments rep-
resented by these proteins. Almost one third of the cyto-
plasmic proteins were mitochondrial proteins (331), with
the Golgi apparatus, endoplasmic reticulum and ribos-
omes representing ~20% of total cytoplasmic proteins.
IPA classified 216 proteins as plasma membrane proteins
with binding activity (159), receptor activity (42), and
transporter activity (36) representing major molecular
functions. Seventeen plasma membrane proteins were
involved in actin binding. Ninety-seven proteins were
classified as extracellular proteins, including matrix pro-
teins, cytokines and growth factors. IPA classified 382 pro-
teins as nuclear, and while many of these included
structural proteins, numerous low abundance transcrip-
tion factors were identified, including STAT1, Sp1, and
steroid receptor RNA activator 1 (SRA1).
Renal cortical protein families
The IPA annotation tool for protein families grouped
1,131 identified proteins into 13 protein families while
835 proteins could not be classified (Figure 4B). Many of
these protein families are enriched in renal cortex, reflect-
ing its specialized functions of filtration and reabsorption.
Transporters and Ion channels
The renal process of reabsorption is accomplished by var-
ious transporters and ion channels located on the plasma
membranes of tubular epithelial cells. In the present
study, 173 transporters and 16 ion channel proteins were
identified. Among them, 41 were located on the plasma
membranes. As shown in Table 1, these plasma mem-
brane transporters are involved in the selective reabsorp-
tion of ions (Na+, K+, Ca2+, Fe3+  and Cl-), glucose,
carboxylic acid, amino acids and water, which function to
keep the concentration of various ions, the volume of
water in the body and the pH of the blood constant. Six
identified plasma membrane transporters have ATP activ-
ities. These proteins provide the essential energy for ions
transporting between the cells and external tissue fluid
[57]. Nine protein transporters, such as syntaxin 3, 4, and
7, were identified that have been implicated in polarized
apical membrane trafficking [58]. In addition to plasma
membrane transporters, we also identified 148 intracellu-
lar transporters and ion channels.
Peptidases
One mechanism for filtered protein reabsorption requires
cleavage by peptidases enriched in the microvillar mem-
branes of the brush border of the proximal tubules. We
identified 73 peptidases in renal cortex, including 6 ami-
nopeptidases, 5 dipeptidases, 4 cathepsins, 8 α-type and 6
β-type proteasome subunits, 5 protease 26S subunit
ATPases and 9 ubiquitin-related peptidases. In our data-
set, 13 identified peptidases are located on plasma mem-
branes. Their potential substrates are those that are
filtered at the glomerulus, such as neuropeptides and gas-
tric hormones [59,60].
Several identified peptidases play critical roles in regulat-
ing vascular function. Kidneys have a major influence on
blood pressure, blood volume and systemic vascular
resistance which are mainly regulated by the renal renin-
angiotensin system (RAS). Several key regulators of RAS
were identified from renal cortex tissue in this study,
including renin-1, angiotensin-converting enzyme (ACE),
aminopeptidase A and aminopeptidase N. Aminopepti-
dase A (APA) is the principal enzyme that metabolizes
angiotensin II to angiotensin III [61]. Aminopeptidase N
(APN) is an abundant metallohydrolase in the brush bor-
der membranes of kidney proximal tubule cells which
degrades angiotensin III to angiotensin IV and, along with
dipeptidylaminopeptidase, degrades angiotensin IV [62].
Transmembrane receptors
A total of 17 transmembrane receptors were identified
from renal cortex, with most having low NSAF values.
One exception was heparin binding protein-44 (HBP-44),
which is intensely expressed in kidneys in the renal tubu-
lar brush border [63]. IGF 1 and 2 receptors have impor-
The theoretical pI and MW of identified proteins Figure 3
The theoretical pI and MW of identified proteins.Proteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
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tant roles in mediating renal proximal tubular transport
processes, glomerular filtration rate and renal plasma flow
levels [64]. Cubilin, an albumin binding protein, is heav-
ily expressed in the kidney proximal tubule brush border,
and plays a critical role in the uptake of albumin by the
proximal tubule [65,66]. We identified β1-integrin, which
localizes to the basolateral aspect of epithelial cells and
mediates adhesion of renal epithelial cells to the underly-
ing matrix [67].
Kinases, phosphatases, and transcription regulators
A total of 80 kinases and 41 phosphatases were identified,
and most of these proteins had low NSAF values. We iden-
tified 113 transcription regulators including CREB1, JUN,
SP1, STAT1 and STAT3. IPA knowledge base indicated that
one third of the identified transcription regulators previ-
ously have been found to be expressed in mouse kidney,
while the remaining two-thirds of the identified transcrip-
tion regulators, such as AT-binding transcription factor 1
(ATBF1), endothelial differentiation-related factor 1
IPA classification of all identified proteins by (4A) subcellular location and (4B) protein families Figure 4
IPA classification of all identified proteins by (4A) subcellular location and (4B) protein families.Proteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
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(EDF1), and steroid receptor RNA activator 1 (SRA1),
have not previously been associated with renal tissue.
Translation regulator
In this present dataset, there were 36 translation regula-
tors, of which there were 23 translation initiation factors,
9 elongation factors, 2 polyadenylate-binding proteins, 1
poly(rC)-binding protein and 1 ribosomal protein. The
identified translation initiation factors accounted for half
of the translation initiation factors present in SWISSPROT
mouse protein database and included the subunits of all
the elF1 to elF6 subfamilies.
Enzymes
Enzymes represented the largest group of classified pro-
teins in our dataset. Out of the 559 enzymes, 425 were
classified based on their EC numbers. These 425 enzymes
included 177 oxidoreductases, 83 transferases, 76 hydro-
lases, 25 lyases, 32 isomerases and 32 ligases. More than
half of identified oxidoreductases were primarily mito-
chondrial proteins, and included 33 NADH dehydroge-
nases, 15 cytochrome C oxidase/reductase and 3
superoxide dismutases. We were able to identify ~73% of
NADH dehydrogenase proteins that were present in
SWISSPROT mouse protein database, indicating that the
method we have used provides high proteome coverage.
Cytokines, growth factors, and renal disease
Interestingly, several cytokines and growth factors were
identified that previously have been implicated in renal
pathology. For example, up-regulated renal macrophage
migration inhibitory factor (MIF) expression is closely
correlated with macrophage accumulation, renal tissue
damage and renal function impairment [68,69]. Its
expression was an order of magnitude higher than other
identified cytokines based on NSAF. Growth-arrested-spe-
cific protein 6 (GAS6) and its receptor tyrosine kinase Axl
play a fundamental role in inflammatory renal disease
[70,71]. EGF is a well known inducer of proliferation of
renal epithelial cells, and its expression in the human kid-
ney by far exceeds that in other tissues [72,73]. TGF-β has
been implicated in the progression of numerous prolifer-
ative renal diseases [74], but our identification of this
growth factor from mouse renal cortex is the first using
global proteomics methods. Finally, while glia matura-
tion factor beta (GMFB) has been considered a brain-spe-
cific growth factor since its expression is largely restricted
to this organ, recent studies have reported induction of
the GMFB gene in renal proximal tubular cells by pro-
teinuria [75], and GMFB has been implicated in a renal
cell tumorogenesis in hypoxia [76]. The observation that
these pathology-associated proteins were identified in
young, normal wild-type mice suggests that such proteins
have a role in normal renal physiology, but can mediate
disease processes when expression is out of homeostatic
balance.
GO classification of molecular function
We next subjected the protein dataset to GO analysis
using DAVID 2007 [77], hosted by the National Institute
of Allergy and Infectious Diseases (NIAID). This approach
minimizes bias in the classification of proteins in our
dataset into molecular functions [78] and differed slightly
from the IPA classification. DAVID recognized all 1,966
Mus musculus unique Uniprot accession numbers and
annotated them to map to the GO molecular function
terms shown graphically in Figure 5. Many proteins
mapped to multiple functions. Binding activity, defined
as the selective interaction of a molecule with one or more
specific sites on another molecule, described 65% of all
proteins. Major binding categories included protein
(588), metal ion (375), nucleotide (349), ATP (189),
Table 1: Subgroups of renal proteins with transporter and ion channel activity
Sub groups of proteins with transporter activity # of proteins Sub groups of proteins with transporter activity # of proteins
Plasma membrane transporter Intracellular transporter
Cation binding 18 Protein transporter 61
Na+, K+ ion 15 P-P-bond-hydrolysis-driven 26
Protein transporter 9 ATPase activity 25
Organic acid 7 H+-transporting ATP synthesis activity 21
Carboxylic acid 7 Nucleotide binding 20
Amino acid 6 ATP binding 17
ATPase activity 6 Golgi vesicle transport 12
Chloride 5 Ion channel activity 9
ATP binding 5 Voltage-gated ion channel activity 4
Nucleotide binding 5 Iron ion binding 4
Sugar transporter 3 Chloride transport 3
Ca2+ channel 2 Microtubule motor activity 3
Iron 1
Water 1Proteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
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RNA (159), actin (76), and lipid (51) binding. Catalytic
activity involved 41% of all proteins. Transporter activity
accounted for 223 proteins, more than the ~200 proteins
with transporter activity identified with IPA; carrier activ-
ity (transfer of a specific substance or related group of sub-
stances from one side of the membrane to the other)
accounted for ~52% of all proteins in this category. As
shown in Figure 5, 165 proteins were identified with
structural molecule activity. Motor activity (catalysis of
movement along a polymeric molecule such as a microfil-
ament or microtubule, coupled to the hydrolysis of a nucl-
eoside triphosphate) involved 27 proteins, and included
numerous myosin, dynein, kinesin, and dynactin family
members. Eighteen proteins were associated with antioxi-
dant activity within the renal cortex (see Additional file 4).
This diversity of molecular functions attests to the validity
of the unbiased, comprehensive, multidimensional LC-
MS approach.
Comparison of renal cortical and glomerular proteomes
We compared a purified glomerular proteome established
by Miyamoto et al [21] from one human kidney with our
mouse renal cortical proteome. Both approaches used
charge prefractionation strategies – solution phase IEF for
the human glomerular work and SCX for the mouse cortex
– prior to LC-MS/MS. However, Miyamoto et al searched
their mass spectrometry data against several protein data-
bases, often with redundancy, while we limited our pro-
tein identification to SWISSPROT database with the
minimum level of redundancy. As shown in Figure 6A, the
proteome differs between cortex and glomerulus. About
48% of our renal cortical proteome (940 proteins) was
also present in the glomerular proteome, while 1026 pro-
teins were unique to the renal cortex. We calculated NSAF
values for the proteins listed in the glomerular dataset,
then compared the 100 most abundant (highest NSAF
scores) proteins in the two datasets (Figure 6B). While rel-
atively similar numbers of highly abundant proteins were
identified in the cytoplasm and nucleus, striking differ-
ences in the number of mitochondrial (enriched in the
renal cortex) versus cytoskeletal (enriched in the glomeru-
lar proteome) proteins were identified. Almost one half of
the 100 most abundant cortical proteins were mitochon-
drial versus less than 10% for the glomerular proteins. It
is not surprising that cytoskeletal proteins are enriched in
the glomerular proteome since endothelial cells and
mesangial cells are two major cell types in glomerulus.
Endothelial cells have a complex cytoskeleton and
mesangial cells are modified smooth muscle cells which
are rich in cytoskeletal proteins. In contrast, tubular epi-
Comparison of the proteins in one published human glomer- ular proteome dataset with the renal cortical proteome  listed in Additional file 3 Figure 6
Comparison of the proteins in one published human glomer-
ular proteome dataset with the renal cortical proteome 
listed in Additional file 3. A. the diagram of the overlapping 
between the two datasets. B. Subcellular location distribu-
tion patterns of the 100 most abundant proteins in two data-
sets.
Gene Ontology classification of molecular function Figure 5
Gene Ontology classification of molecular function. Gene 
Ontology (GO) analysis using DAVID 2007, hosted by 
NIAID. GO is a structured, controlled vocabulary that 
describes gene products in terms of their associated biologi-
cal processes, cellular components and molecular functions 
in a species-independent manner. 1,966 Uniprot accession 
numbers [see Additional file 3] were classified by biological 
process. Data are presented as a histogram of the relevant 
biological processes identified and shown as a percentage of 
the total identified proteins that fall within each category.Proteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
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thelial cells are the predominant cell type in the renal cor-
tex and account for more than 80% of renal parenchymal
cells [79]. Tubular epithelial cells are richly supplied with
mitochondria and are highly dependent on mitochon-
drial energy production for their physiological roles of
absorption and secretion [79,80]. Our findings are con-
sistent with the suggestion that the glomerular proteome
is representative of only a small subset of the renal cortical
proteome with significant differences in protein families
and their expression level. It is noteworthy that we com-
pared the mouse renal cortical proteome identified in this
study to a human renal glomerular proteome since the lat-
ter is the largest, global map of the glomerular proteome
to date. Ultimately, it will be interesting to compare the
mouse cortical and glomerular proteomes when a suitable
dataset for the latter becomes available. It is important to
emphasize that variability from the use of MS can under-
mine the usefulness of NSAF and the reliability of data
among different laboratories or experiments. Therefore,
when we performed comparisons of renal cortical and
glomerular proteomes, we used the NSAF value to deter-
mine the relative abundance of identified proteins within
each dataset rather than compare the NSAF value of the
same proteins across the two datasets.
Comparison of renal cortical and urinary proteomes
A large number of urinary proteome studies have been
performed [10,17,81-83], and one of the most important
findings of these studies is that only ~30% of identified
proteins are plasma-derived proteins. The remaining
~70% proteins in urinary proteome may be derived from
renal cells [17], and the identification of kidney plasma
membrane proteins in urine supports this hypothesis
[81,83]. Since few studies have directly compared urinary
and renal proteomes, we compared our dataset with two
large datasets of the urinary proteome obtained from nor-
mal human subjects [81,83]. In order to compare the dif-
ferent protein identifiers, the protein IDs in each dataset
were converted to gene symbols. While most hypothetical
proteins in the two urinary proteomes could not be
assigned gene symbols, the total sum of unique gene
products reported in these two urinary proteome datasets
was 1,435. Of these, 437 (30.4%) were identified in our
dataset (see Figure 7 and Additional file 5), indicating that
nearly one third of the proteins in the urine are of renal
cortex origin.
Two possibilities may account for how renal proteins are
delivered into the urine, including: 1) whole kidney cells
or cell fragments are shed into urine, and 2) these proteins
are excreted into urine through exosome formation. In
normal kidneys, exosome formation is the dominant
excretion pathway and whole cell shedding plays a minor
role [83]. This conclusion is supported by our observa-
tions. As shown in Figure 8, there are significant differ-
ences between the subcellular origin of proteins present in
the entire renal cortex compared to the urine. Renal extra-
cellular proteins, plasma membrane proteins, and lyso-
some proteins are enriched in urine, whereas proteins
from other intracellular organelles of kidney cells are not.
For example, 20 of the 28 identified renal lysosome pro-
teins (71%) were found in urine, and only 9% (35) of the
identified renal nuclear proteins were present in urine. We
found that more than one half of the 105 most abundant
renal proteins (58) were not present in urine. The major-
ity (78%) of the most abundant renal proteins not found
in the urine were nuclear (such as histone H2A and his-
tone H2B) and mitochondrial (such as electron transfer
flavoprotein alpha and beta subunit and ubiquinol-cyto-
chrome C reductase) proteins. On the other hand, low-
abundance plasma membrane peptidases, receptors and
transporters were enriched in urine. In addition, all of the
class E vacuolar protein-sorting proteins that were identi-
fied in urine samples and found to mediate exosome for-
mation [81] were present in our dataset. Most proteins in
urinary vesicles previously identified in exosomes from
other cell types [81] are present in our dataset as well.
Concluding remarks
Using a multiple fractionation strategy, a whole tissue
extract of the mouse kidney cortex was analyzed by an
unbiased proteomic approach, yielding a dataset of
~2,000 proteins identified with strict criteria to ensure a
high level of confidence in the protein identifications. As
a result of extracting all proteins from the renal cortex,
Comparison of the proteins in two urinary proteome data- sets with the renal cortical proteome listed in Additional file  2 Figure 7
Comparison of the proteins in two urinary proteome data-
sets with the renal cortical proteome listed in Additional file 
2. The total sum of unique gene products reported in these 
two urinary proteome datasets was 1,435. Of these, 437 
(30.4%) were identified in our dataset.Proteome Science 2008, 6:15 http://www.proteomesci.com/content/6/1/15
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then using an unbiased fractionation scheme involving
prefractionation with SCX followed by LC-MS/MS, we
identified an exceptionally wide range of renal proteins in
terms of pI, MW, hydrophobicity, abundance, and subcel-
lular location. Many of these proteins, such as low-abun-
dance proteins, membrane proteins and proteins with
extreme values in pI or MW are traditionally under-repre-
sented in 2-DE-based proteomic analysis. This dataset rep-
resents the largest and most confident inventory of
proteins present in renal cortical tissue to date, and vali-
dates our fractionation strategy for increasing coverage of
renal proteins. It not only serves as a useful reference for
further experiments characterizing differential expression
of renal cortical proteins induced by diseases, but also
provides a foundation for the development of systems
biology linkages between the dysregulated protein path-
ways and networks in renal diseases such as diabetic
nephropathy.
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